This segment explores Dr. Rossi's clinical experience with cilta-cel as a second-line therapy, focusing on its efficacy and quality-of-life benefits across diverse patient populations.
Video content above is prompted by the following:
Stay up to date on recent advances in the multidisciplinary approach to cancer.